IgG4-Rich Lesions Associated With Intranasal Drug Use Can Mimic IgG4-Related Disease.

Andrew T Turk, David A Gudis
{"title":"IgG4-Rich Lesions Associated With Intranasal Drug Use Can Mimic IgG4-Related Disease.","authors":"Andrew T Turk, David A Gudis","doi":"10.5858/arpa.2023-0474-OA","DOIUrl":null,"url":null,"abstract":"<p><strong>Context.—: </strong>Manifestations of immunoglobulin G4-related disease (IgG4-RD) occur in several organ systems and anatomic locations, including the nasal cavity and paranasal sinuses. Other processes affecting the sinonasal tract, such as chronic rhinosinusitis, aspirin-exacerbated respiratory disease, and nasal polyposis, also involve IgG4.</p><p><strong>Objective.—: </strong>To characterize an association between IgG4 and nasal lesions arising in the clinical context of intranasal drug use.</p><p><strong>Design.—: </strong>The cases of 3 patients (2 with histories of intranasal cocaine abuse, and 1 with intranasal heroin abuse) were evaluated. Clinical features of each case were compiled from the electronic medical record. Histologic morphology of surgical specimens was examined. Immunohistochemical staining was performed to assess involvement of/association with IgG4.</p><p><strong>Results.—: </strong>Clinical features of these lesions included diffuse necrotic fibrinous debris, scarring, and endoscopically evident inflammation. Tissue sections showed acutely and chronically inflamed respiratory-type mucosa with abundant IgG4-positive plasma cells. Although these cases share some aspects in common with IgG4-RD, other definitive characteristics are absent, and notable differences exist.</p><p><strong>Conclusions.—: </strong>This series provides the first demonstration of increased IgG4 expression in nasal lesions associated with intranasal drug use. Despite some similarities, the pathologic processes and IgG4-rich infiltrates in these 3 cases seem to represent a different phenomenon that is not IgG4-RD. Although these lesions contain abundant IgG4-positive cells, they should not be mistaken for or conflated with IgG4-RD.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of pathology & laboratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5858/arpa.2023-0474-OA","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Context.—: Manifestations of immunoglobulin G4-related disease (IgG4-RD) occur in several organ systems and anatomic locations, including the nasal cavity and paranasal sinuses. Other processes affecting the sinonasal tract, such as chronic rhinosinusitis, aspirin-exacerbated respiratory disease, and nasal polyposis, also involve IgG4.

Objective.—: To characterize an association between IgG4 and nasal lesions arising in the clinical context of intranasal drug use.

Design.—: The cases of 3 patients (2 with histories of intranasal cocaine abuse, and 1 with intranasal heroin abuse) were evaluated. Clinical features of each case were compiled from the electronic medical record. Histologic morphology of surgical specimens was examined. Immunohistochemical staining was performed to assess involvement of/association with IgG4.

Results.—: Clinical features of these lesions included diffuse necrotic fibrinous debris, scarring, and endoscopically evident inflammation. Tissue sections showed acutely and chronically inflamed respiratory-type mucosa with abundant IgG4-positive plasma cells. Although these cases share some aspects in common with IgG4-RD, other definitive characteristics are absent, and notable differences exist.

Conclusions.—: This series provides the first demonstration of increased IgG4 expression in nasal lesions associated with intranasal drug use. Despite some similarities, the pathologic processes and IgG4-rich infiltrates in these 3 cases seem to represent a different phenomenon that is not IgG4-RD. Although these lesions contain abundant IgG4-positive cells, they should not be mistaken for or conflated with IgG4-RD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与鼻内用药有关的富含 IgG4 的病变可模拟 IgG4 相关疾病。
背景免疫球蛋白 G4 相关疾病(IgG4-RD)发生在多个器官系统和解剖部位,包括鼻腔和副鼻窦。影响鼻窦道的其他过程,如慢性鼻窦炎、阿司匹林加重的呼吸道疾病和鼻息肉病,也涉及 IgG4.Objective.-:描述 IgG4 与鼻腔病变之间的关联:对 3 例患者(2 例有鼻内滥用可卡因史,1 例有鼻内滥用海洛因史)的病例进行了评估。每个病例的临床特征均来自电子病历。检查了手术标本的组织学形态。进行免疫组化染色以评估 IgG4.Results.- 的参与/关联:这些病变的临床特征包括弥漫性坏死纤维碎屑、瘢痕和内镜下明显的炎症。组织切片显示急性和慢性呼吸道型粘膜发炎,并伴有大量 IgG4 阳性浆细胞。虽然这些病例在某些方面与 IgG4-RD 相同,但却没有其他明确的特征,而且存在明显的差异:这一系列病例首次证明了鼻腔病变中与鼻内用药相关的 IgG4 表达增多。尽管有一些相似之处,但这 3 个病例的病理过程和富含 IgG4 的浸润似乎代表了一种不同的现象,并非 IgG4-RD。虽然这些病变含有大量 IgG4 阳性细胞,但不应误认为或与 IgG4-RD 混为一谈。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies. Ethical and Regulatory Perspectives on Generative Artificial Intelligence in Pathology. Reduced Plasma Selenoprotein P Is Associated With Type I Antithrombin Deficiency and a Prothrombotic State. The Anatomic Pathology Hospitalist Model. Histologic Features of Liver Injury Associated With SARS-CoV-2 Messenger RNA Vaccines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1